Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003009036 | SCV003296104 | likely benign | Bethlem myopathy 1A | 2022-08-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002999656 | SCV003603928 | uncertain significance | Inborn genetic diseases | 2024-01-08 | criteria provided, single submitter | clinical testing | The c.3371C>A (p.A1124E) alteration is located in exon 8 (coding exon 7) of the COL6A3 gene. This alteration results from a C to A substitution at nucleotide position 3371, causing the alanine (A) at amino acid position 1124 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Revvity Omics, |
RCV003146717 | SCV003832970 | uncertain significance | not provided | 2019-06-24 | criteria provided, single submitter | clinical testing |